Access to anti-retroviral drugs, male in Ghana

Ghana: Access to anti-retroviral drugs, male was 40.0% in 2024. ◆ Volatile

Latest (2024)
40.0%
Change on year
up 5.3%
World rank
131st
of 141 countries
All-time high
40.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Ghana, 2000–2024

0102030402000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 1 %2005: 2 %2006: 3 %2007: 5 %2008: 9 %2009: 13 %2010: 17 %2011: 21 %2012: 24 %2013: 24 %2014: 26 %2015: 17 %2016: 20 %2017: 23 %2018: 24 %2019: 26 %2020: 29 %2021: 32 %2022: 37 %2023: 38 %2024: 40 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Ghana stood at 40.0%. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 5.3% on the previous year and up 53.8% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Ghana peaked at 40.0% in 2024 and was at its lowest, 0.0%, in 2000.

Ghana ranks 131st of 141 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Ghana, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Ghana, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 2.0% +100.0%
2006 3.0% +50.0%
2007 5.0% +66.7%
2008 9.0% +80.0%
2009 13.0% +44.4%
2010 17.0% +30.8%
2011 21.0% +23.5%
2012 24.0% +14.3%
2013 24.0% +0.0%
2014 26.0% +8.3%
2015 17.0% -34.6%
2016 20.0% +17.6%
2017 23.0% +15.0%
2018 24.0% +4.3%
2019 26.0% +8.3%
2020 29.0% +11.5%
2021 32.0% +10.3%
2022 37.0% +15.6%
2023 38.0% +2.7%
2024 40.0% +5.3%

Averages by decade

DecadeAverage LowestHighest Years
2000s 3.3% 0.0% 13.0% 10
2010s 22.2% 17.0% 26.0% 10
2020s 35.2% 29.0% 40.0% 5

Countries ranked near Ghana

  1. 128 Mongolia 42.0% compare
  2. 128 Philippines 42.0% compare
  3. 130 Suriname 41.0% compare
  4. 131 Congo 40.0% compare
  5. 133 Djibouti 28.0% compare
  6. 133 Fiji 28.0% compare
  7. 133 Tunisia 28.0% compare

See the full ranking of 160 places →

More gender data for Ghana

All data for Ghana →

Frequently asked questions

What is access to anti-retroviral drugs, male in Ghana?
Access to anti-retroviral drugs, male in Ghana was 40.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Ghana?
The highest recorded value was 40.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Ghana?
The lowest recorded value was 0.0% in 2000.
How does Ghana rank for access to anti-retroviral drugs, male?
Ghana ranks 131st out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Ghana?
Over the last ten years it is up 53.8%. The long-run trend across the full record is volatile.
Where does this Ghana data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Ghana. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/ghana/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/ghana/">Access to anti-retroviral drugs, male in Ghana</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.